NO923798L - Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater - Google Patents

Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater

Info

Publication number
NO923798L
NO923798L NO92923798A NO923798A NO923798L NO 923798 L NO923798 L NO 923798L NO 92923798 A NO92923798 A NO 92923798A NO 923798 A NO923798 A NO 923798A NO 923798 L NO923798 L NO 923798L
Authority
NO
Norway
Prior art keywords
carboxylic acid
imidazole
acylals
procedure
preparation
Prior art date
Application number
NO92923798A
Other languages
English (en)
Norwegian (no)
Other versions
NO923798D0 (no
Inventor
Dieter Binder
Josef Weinberger
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of NO923798D0 publication Critical patent/NO923798D0/no
Publication of NO923798L publication Critical patent/NO923798L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO92923798A 1991-10-04 1992-09-30 Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater NO923798L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198791A AT398202B (de) 1991-10-04 1991-10-04 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO923798D0 NO923798D0 (no) 1992-09-30
NO923798L true NO923798L (no) 1993-04-05

Family

ID=3525398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923798A NO923798L (no) 1991-10-04 1992-09-30 Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater

Country Status (22)

Country Link
US (1) US5298519A (zh)
EP (1) EP0535420A1 (zh)
JP (1) JP2544565B2 (zh)
CN (1) CN1032856C (zh)
AT (1) AT398202B (zh)
AU (1) AU649357B2 (zh)
CA (1) CA2079735A1 (zh)
CZ (1) CZ301992A3 (zh)
FI (1) FI924353A (zh)
HR (1) HRP920817A2 (zh)
HU (1) HUT62291A (zh)
IL (1) IL103329A (zh)
LV (1) LV10256B (zh)
MY (1) MY108350A (zh)
NO (1) NO923798L (zh)
NZ (1) NZ244320A (zh)
RU (1) RU2105764C1 (zh)
SI (1) SI9200240A (zh)
SK (1) SK301992A3 (zh)
TW (1) TW223073B (zh)
YU (1) YU48290B (zh)
ZA (1) ZA927205B (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.
CN101024643A (zh) * 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
CN101195615B (zh) * 2006-12-06 2013-03-27 深圳市信立泰资产管理有限公司 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物
EP2103610B1 (en) * 2006-12-06 2011-09-21 Shanghai Allist Pharmaceutical., Inc. Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101317842A (zh) 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101367795B (zh) * 2007-08-17 2012-05-02 上海艾力斯生物医药有限公司 一种咪唑-5-羧酸衍生物及其制备方法
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
KR950009860B1 (ko) * 1989-06-30 1995-08-29 이. 아이. 듀퐁 드 네모아 앤드 캄파니 융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물
DE69013607T2 (de) * 1989-08-02 1995-03-02 Takeda Chemical Industries Ltd Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung.
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung

Also Published As

Publication number Publication date
TW223073B (zh) 1994-05-01
JP2544565B2 (ja) 1996-10-16
RU2105764C1 (ru) 1998-02-27
ATA198791A (de) 1994-02-15
NZ244320A (en) 1995-01-27
LV10256B (en) 1995-04-20
NO923798D0 (no) 1992-09-30
HUT62291A (en) 1993-04-28
SI9200240A (en) 1993-06-30
CA2079735A1 (en) 1993-04-05
IL103329A0 (en) 1993-03-15
IL103329A (en) 1996-10-31
JPH05310731A (ja) 1993-11-22
CZ301992A3 (en) 1993-08-11
FI924353A0 (fi) 1992-09-29
HRP920817A2 (en) 1996-08-31
YU48290B (sh) 1998-05-15
ZA927205B (en) 1993-03-23
FI924353A (fi) 1993-04-05
US5298519A (en) 1994-03-29
AU649357B2 (en) 1994-05-19
AU2617692A (en) 1993-04-08
CN1032856C (zh) 1996-09-25
LV10256A (lv) 1994-10-20
MY108350A (en) 1996-09-30
SK301992A3 (en) 1995-10-11
HU9203149D0 (en) 1992-12-28
CN1071426A (zh) 1993-04-28
YU87592A (sh) 1995-10-03
EP0535420A1 (de) 1993-04-07
AT398202B (de) 1994-10-25

Similar Documents

Publication Publication Date Title
NO923798L (no) Fremgangsmaate for fremstilling og anvendelse av nye acylaler av imidazol-5-karboksylsyrederivater
MXPA04006003A (es) Derivados del acido fenilpropionico substituidos como agonistas al receptor alfa activado-proliferativo de peroxisoma (ppar) humano.
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
NO20051265L (no) Anvendelse av og noen nye imidazopyridiner
SG151260A1 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitors
IL166412A0 (en) Novel use of benzothiazole derivatives
NO20055655D0 (no) Anvendelse av azetidinkarboksamidderivater i terapi
IL169257A0 (en) Cycloalkene dicarboxylic acid compounds as anti-infammatory, immunomodulatory and anti-proliferatory agents
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
DE60014916D1 (de) Die Verwendung eines Benzimidazoles zur Herstellung eines Medikamentes zur Krebsvorbeugung
DK0538192T3 (da) Hidtil ukendte 17beta-substituerede aza-androstan-derivater
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
ATE337827T1 (de) N-aryl-4,5-diaminopyrazole und diese verbindungen enthaltende färbemittel
SE0104333D0 (sv) Therapeutic agents
EA200500133A1 (ru) Производные пирролидина в качестве антагонистов окситоцина
MXPA02003952A (es) Derivados de imidazol como inhibidores de la fosfodieterasa vii.
NO843296L (no) Fremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet
ATE446284T1 (de) Indolderivate mit einer acetylengruppe als ppar- aktivatoren
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
HUP0300391A2 (hu) Prosztaglandinnal rokon vegyületek alkalmazása szemen belüli túlnyomás és glaukóma kezelésére alkalmas készítmény előállítására
GB1164496A (en) 0-Oxaphenanthridine Derivatives and Method for the Preparation
YU89903A (sh) Derivati oksazola koji su supstituisani karboksilnom kiselinom za primenu kao ppar-alfa i -gama aktivatori u lečenju dijabetesa
TH50555A (th) อนุพันธ์อิมิดาโซไพริดินที่เป็นตัวยับยั้งฟอสฟอไดเอสเทอเรส vii